This is with reference to our intimation dated May 28, 2025, submitted under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, regarding the appointment ....
Awaiting price reaction for this filing.
Garodia Chemicals has corrected a typographical error in its earlier May 28, 2025 intimation regarding the appointment of Mrs. Bhagyashri Nilesh Devrale as Additional Non-Executive Director. The original filing mistakenly stated the appointment date as March 10, 2025; the correct date is May 28, 2025, when the Monitoring Committee approved her appointment. Mrs. Devrale is a software developer with 14 years of experience at a multinational company and is not related to any existing director on the board. The clarification was signed by the Erstwhile Resolution Professional, indicating the company remains under the Corporate Insolvency Resolution Process (CIRP).
This is purely a procedural correction with no change in substance — the appointment itself is unchanged, so there is no material impact on shareholders or the stock price. Investors should note that the company is still operating under CIRP, which remains the key factor to watch.